BNP Paribas Financial Markets
LNAI

BNP Paribas Financial Markets’s Lunai Bioworks LNAI Stock Holding History

BNP Paribas Financial Markets’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78 Buy
24
+4
+20% +$11 ﹤0.01% 5805
2026
Q1 		$66 Hold
20
– – ﹤0.01% 5703
2025
Q4 		$142 Hold
20
– – ﹤0.01% 5591
2025
Q3 		$229 Sell
20
-77
-79% -$1.48K ﹤0.01% 5381
2025
Q2 		$2.23K Buy
97
+28
+41% +$782 ﹤0.01% 5046
2025
Q1 		$3K Sell
69
-141
-67% -$9.02K ﹤0.01% 4927
2024
Q4 		$14K Buy
210
+78
+59% +$5.18K ﹤0.01% 4787
2024
Q3 		$5.11K Buy
132
+80
+154% +$5.55K ﹤0.01% 3842
2024
Q2 		$7.24K Buy
52
+37
+247% +$5.04K ﹤0.01% 3748
2024
Q1 		$3.08K Hold
15
– – ﹤0.01% 3776
2023
Q4 		$3.79K Sell
15
-27
-64% -$7.4K ﹤0.01% 3774
2023
Q3 		$15.2K Hold
42
– – ﹤0.01% 3588
2023
Q2 		$1.92K Sell
42
-85
-67% -$6.52K ﹤0.01% 3728
2023
Q1 		$9.27K Buy
127
+59
+87% +$5.19K ﹤0.01% 3558
2022
Q4 		$5.59K Sell
68
-47
-41% -$6.31K ﹤0.01% 3659
2022
Q3 		$16.6K Buy
115
+53
+85% +$9.66K ﹤0.01% 4122
2022
Q2 		$9.53K Buy
62
+61
+6,100% +$27.9K ﹤0.01% 3756
2022
Q1 		$710 Sell
1
-1
-50% -$533 ﹤0.01% 3997
2021
Q4 		$948 Hold
2
– – ﹤0.01% 4057
2021
Q3 		$969 Sell
2
-39
-95% -$19.1K ﹤0.01% 3877
2021
Q2 		$16.3K Sell
41
-28
-41% -$9.12K ﹤0.01% 3587
2021
Q1 		$19.7K Buy
69
+34
+97% +$9.99K ﹤0.01% 3762
2020
Q4 		$8.22K Sell
35
-4
-10% -$1.01K ﹤0.01% 3936
2020
Q3 		$11.2K Buy
39
+32
+457% +$10.1K ﹤0.01% 3949
2020
Q2 		$2.46K Sell
7
-46
-87% -$13.9K ﹤0.01% 4161
2020
Q1 		$12.8K Buy
53
+17
+47% +$5.05K ﹤0.01% 3995
2019
Q4 		$14.4K Buy
36
+34
+1,700% +$14.9K ﹤0.01% 4079
2019
Q3 		$1.08K Hold
2
– – ﹤0.01% 4400
2019
Q2 		$567 Buy
+2
New +$975 ﹤0.01% 4397

Other funds holding LNAI

GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

BNP Paribas Financial Markets's LNAI Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Lunai Bioworks (LNAI) stake by 20% in Q2 2026, buying an estimated $11 and bringing the position to 24 shares worth $78. The position accounts for ﹤0.01% of the portfolio, ranked #5805.

BNP Paribas Financial Markets first reported a position in LNAI in Q2 2019 and has held it in 29 quarters since. The position peaked at $19.7K in Q1 2021. 15 funds tracked by Wall St. Rank hold LNAI as of Q2 2026.

  • BNP Paribas Financial Markets held 24 shares of Lunai Bioworks worth $78 as of Q2 2026.
  • BNP Paribas Financial Markets bought 4 Lunai Bioworks shares in Q2 2026, an estimated $11.
  • Lunai Bioworks made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5805 holding.
  • BNP Paribas Financial Markets first reported a position in Lunai Bioworks in Q2 2019 and has held it in 29 quarters since.
  • BNP Paribas Financial Markets's Lunai Bioworks position peaked at $19.7K in Q1 2021.
  • 15 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.